Sodium Orthophosphate (32P) Solution for Injection
Strontium chloride 89SrCl2 POLATOM is indicated for the palliation of pain from bone metastases. The best documented use of strontium chloride-89 is in case of osteoblastic or mixed metastases from prostate cancer and breast cancer, it can also be used in cases of other tumorus resulting in osteoblastic (scintigraphicaly “hot”) metastases to the bone.
Bone scintigraphy is recommended prior to Strontium-89 chloride therapy.
Most common indication for strontium chloride is the treatment of pain in patients with multiple disseminated metastases (chemotherapy, hormonal therapy, treatment with analgesics including narcotic drugs), who have not responded to previous conventional therapies).
|Active Substance||Strontium (89Sr) Chloride 37.5 MBq/ml|
|Ordering Deadline||Thursday two weeks before Delivery (NZT)|
NOTE: Please check with us for availability and quantity before ordering.